News

Media Release

Lucence Launches DeepMARK™ for Profiling of SARS-CoV-2 Subgenomic RNA

October 7, 2020
Media Release

Lucence Launches SAFER™ Technology Suite for Accurate COVID-19 Detection Using Naso-Oropharyngeal Saliva

August 18, 2020
Media Release

Lucence and Akribis Collaborate on COVID-19 Saliva Processing Automated Platform to Enable Mass Testing

July 2, 2020
Media Release

Lucence, A*STAR Share Study Data Showing SAFER™ Sample Saliva Collection Kit for COVID-19 Inactivates Collected Virus

June 16, 2020
Highlights

Lucence Shares Data at ASCO20 Demonstrating High Sensitivity of AmpliMARK™ Sequencing Technology in Detecting Clinically Relevant Biomarkers in Lung Cancer

May 26, 2020
Highlights

Lucence announces the launch of SARS-CoV-2 RNA RT-PCR clinical testing service to support Singapore’s anti-COVID-19 efforts.

May 25, 2020
Media Release

Genomics company Lucence develops viral sample collection medical device for COVID-19 diagnosis and surveillance

March 20, 2020
Media Release

Lucence Presents Data Demonstrating Potential of AmpliMARK™ Powered Sequencing to Detect Genomic Alterations at High Sensitivity in Blood Cancers

January 14, 2020
Highlights

Lucence Raises USD $20M Series A Led by IHH Healthcare to Advance Liquid Biopsy for Early Detection of Multiple Cancers

November 20, 2019
Highlights

Introducing Our New Company Brand

November 15, 2019
Announcements

Lucence Diagnostics and Tan Tock Seng Hospital Collaborate on Decision Support Tool to Reduce Risks of Liver Cancer Surgery

October 9, 2019
Highlights

Lucence Diagnostics Singapore Lab Receives CLIA Certification

September 27, 2019
View More
Events

Lucence wows crowd with cancer-care impact at A*STAR event

September 10, 2019
Events

PD-L1 IHC profiling and implications on immunotherapy for breast cancer management: 7th Genomics Tumor Board Meeting

September 6, 2019
Events

Lucence Diagnostics at Liquid Biopsy Summit in San Francisco

June 20, 2019
Events

Invited Talk at Genome Institute of Singapore Innovation Seminar

June 12, 2019
Events

Lucence Diagnostics Showcases LiquidHALLMARK™ at ASCO 2019

June 10, 2019
Events

Dr. Min-Han Tan Speaks at Pujiang Innovation Forum 2019

May 29, 2019
Events

Predicting Immunotherapy Outcomes: 6th Genomics Tumor Board Meeting

March 12, 2019
Events

Precision Therapy for Gynaecology Cancers: 5th Genomics Tumor Board Meeting

December 4, 2018
Events

Lucence Diagnostics Presents LiquidHALLMARK® at ESMO Asia 2018 Congress

November 27, 2018
Events

Lucence Diagnostics Presents Largest Genetic Study of Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

November 2, 2018
Events

Genomics Tumor Board #5: Precision Therapy in Gynaecologic Cancers

October 25, 2018
Events

Dr Min-Han Tan Speaks at Best of ASCO Philippines

October 19, 2018
View More

Other home-grown firms in virus fight

 The Straits Times August 17, 2020

Singapore studying the feasibility, reliability of saliva tests for Covid-19

 The Straits Times June 25, 2020

Coronavirus: New kit allows Covid-19 test samples to be transported at room temperature

 The Straits Times March 24, 2020

What Singapore can teach the U.S. about responding to Covid-19

 STAT March 24, 2020

Lucence Dx Targets Late-Stage Lung Cancer Monitoring With 2020 US Entry

 GenomeWeb January 27, 2020

Singapore Investors Plow into Healthcare Startups

 Nikkei Asian Review December 24, 2019

Lucence Raises $20 Million Sequence A for its Non-invasive Cancer Screening Know-how

 DRNewsIndustry November 30, 2019

Lucence Raises $20M to Advance Liquid Biopsy

 BioSpectrum November 28, 2019

Firm Behind Non-invasive Cancer Tests Receives $27m Funding

 The Straits Times November 25, 2019

Malaysia’s IHH Leads $20m Injection for Cancer-test Startup Lucence

 Nikkei Asian Review November 22, 2019

Singapore: IHH Leads Series A Round for Lucence

 LaingBuisson November 21, 2019

Lucence Attracts $20M in Series A to Scale Up Operations

 BioWorld November 21, 2019
View More
Need Help?